Cargando…
Proposed approach to the challenging management of progressive gastroesophageal reflux disease
The progression of gastroesophageal reflux disease (GERD) in patients who are taking proton pump inhibitors (PPIs) has been reported by several investigators, leading to concerns that PPI therapy does not address all aspects of the disease. Patients who are at risk of progression need to be identifi...
Autores principales: | Labenz, Joachim, Chandrasoma, Parakrama T, Knapp, Laura J, DeMeester, Tom R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162253/ https://www.ncbi.nlm.nih.gov/pubmed/30283600 http://dx.doi.org/10.4253/wjge.v10.i9.175 |
Ejemplares similares
-
Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making
por: Klenzak, Scott, et al.
Publicado: (2018) -
Endoscopic anti-reflux therapy for gastroesophageal reflux disease
por: Rodríguez de Santiago, Enrique, et al.
Publicado: (2021) -
Focus on gastroesophageal reflux disease in patients with cystic fibrosis
por: Bongiovanni, Annarita, et al.
Publicado: (2020) -
Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022) -
Risk factors for gastroesophageal reflux disease and analysis of genetic contributors
por: Argyrou, Alexandra, et al.
Publicado: (2018)